Welcome to our dedicated page for Natixis Vaughan Nelson Select ETF news (Ticker: VNSE), a resource for investors and traders seeking the latest updates and insights on Natixis Vaughan Nelson Select ETF stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Natixis Vaughan Nelson Select ETF's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Natixis Vaughan Nelson Select ETF's position in the market.
Natixis Investment Managers (Natixis IM) announced the liquidation of the Natixis Vaughan Nelson Mid Cap ETF (NYSE: VNMC). The Board of Trustees decided to close the fund on the recommendation of Natixis Advisors, The fund will stop accepting purchase orders on July 25, 2024, and will cease trading on NYSE Arca that same day. Liquidation proceeds are expected to be distributed to shareholders by July 30, 2024. Shares not sold by July 25 will be automatically terminated and canceled, with shareholders receiving a distribution based on the net asset value. The fund will increase its cash holdings and cease pursuing its investment objective during the liquidation process.
Summary not available.